| Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma J Zhao, AX Chen, RD Gartrell, AM Silverman, L Aparicio, T Chu, ... Nature medicine 25 (3), 462-469, 2019 | 657 | 2019 |
| Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics RD Seban, JS Nemer, A Marabelle, R Yeh, E Deutsch, S Ammari, ... European journal of nuclear medicine and molecular imaging 46 (11), 2298-2310, 2019 | 103 | 2019 |
| Quantitative analysis of immune infiltrates in primary melanoma RD Gartrell, DK Marks, TD Hart, G Li, DR Davari, A Wu, Z Blake, Y Lu, ... Cancer immunology research 6 (4), 481-493, 2018 | 100 | 2018 |
| Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death PM Kulkarni, EJ Robinson, JS Pradhan, RD Gartrell-Corrado, BR Rohr, ... Clinical Cancer Research 26 (5), 1126-1134, 2020 | 99 | 2020 |
| Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway SP Weisberg, DJ Carpenter, M Chait, P Dogra, RD Gartrell-Corrado, ... Cell reports 29 (12), 3916-3932. e5, 2019 | 90 | 2019 |
| An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma B Acs, FS Ahmed, S Gupta, PF Wong, RD Gartrell, J Sarin Pradhan, ... Nature communications 10 (1), 1-7, 2019 | 77 | 2019 |
| Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy A Hanoteau, JM Newton, R Krupar, C Huang, HC Liu, A Gaspero, ... Journal for immunotherapy of cancer 7 (1), 1-19, 2019 | 71 | 2019 |
| Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition JM Newton, A Hanoteau, HC Liu, A Gaspero, F Parikh, ... Journal for immunotherapy of cancer 7 (1), 1-21, 2019 | 68 | 2019 |
| COVID‐19 disease in New York City pediatric hematology and oncology patients B Gampel, AGT Lucas, L Broglie, RD Gartrell‐Corrado, MT Lee, J Levine, ... Pediatric blood & cancer, 2020 | 66 | 2020 |
| Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers C Grigg, Z Blake, R Gartrell, A Sacher, B Taback, Y Saenger Seminars in oncology 43 (6), 638-646, 2016 | 64 | 2016 |
| Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker AX Chen, RD Gartrell, J Zhao, PS Upadhyayula, W Zhao, J Yuan, ... Genome medicine 13 (1), 1-13, 2021 | 63 | 2021 |
| The role of oncolytic viruses in the treatment of melanoma CAY Bayan, AT Lopez, RD Gartrell, KM Komatsubara, M Bogardus, ... Current oncology reports 20 (10), 1-14, 2018 | 38 | 2018 |
| Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid KM Beck, J Dong, LJ Geskin, VP Beltrani, RG Phelps, RD Carvajal, ... Journal for ImmunoTherapy of Cancer 4 (1), 1-5, 2016 | 37 | 2016 |
| Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual … Z Blake, DK Marks, RD Gartrell, T Hart, P Horton, SK Cheng, B Taback, ... Journal for ImmunoTherapy of Cancer 6 (1), 1-8, 2018 | 33 | 2018 |
| Timing of adjuvant radiotherapy in glioblastoma patients: a single-institution experience with more than 400 patients TJC Wang, A Jani, JP Estrada, TH Ung, DS Chow, JE Soun, S Saad, ... Neurosurgery 78 (5), 676-682, 2016 | 32 | 2016 |
| Prognostic and predictive immunohistochemistry-based biomarkers in cancer and immunotherapy EM Rizk, RD Gartrell, LW Barker, CL Esancy, GG Finkel, DD Bordbar, ... Hematology/Oncology Clinics 33 (2), 291-299, 2019 | 30 | 2019 |
| Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma MR Moore, ID Friesner, EM Rizk, BT Fullerton, M Mondal, MH Trager, ... Scientific reports 11 (1), 1-11, 2021 | 23 | 2021 |
| Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. J Zhao, AX Chen, RD Gartrell, AM Silverman, L Aparicio, T Chu, ... Nature Medicine 25 (6), 1022-1022, 2019 | 23 | 2019 |
| Quantitative analysis of immune infiltrates in primary melanoma. Cancer Immunol Res. 2018; 6: 481–493. doi: 10.1158/2326-6066 RD Gartrell, DK Marks, TD Hart, G Li, DR Davari, A Wu, Z Blake, Y Lu, ... CIR-17-0360.[PMC free article][PubMed][CrossRef][Google Scholar], 0 | 23 | |
| Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma RD Gartrell-Corrado, AX Chen, EM Rizk, DK Marks, MH Bogardus, ... Cancer research 80 (5), 1078-1087, 2020 | 20 | 2020 |
